The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.598
Bid: 1.594
Ask: 1.598
Change: 0.012 (0.76%)
Spread: 0.004 (0.251%)
Open: 1.58
High: 1.606
Low: 1.57
Prev. Close: 1.586
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results - Separate Statements

13 May 2024 07:00

RNS Number : 0690O
Commercial Intnl Bank (Egypt) SAE
12 May 2024
 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements 

March 31, 2024

Condensed Separate Interim Statement of Financial Position as at March 31, 2024

 

Notes

Mar. 31, 2024

 

Dec. 31, 2023

 

 

Assets

 

 

 

Cash and balances at the central bank

9

36,542,863

 

71,747,343

Due from banks

10

291,979,960

 

230,709,419

Loans and advances to banks, net

12

1,140,170

 

822,448

Loans and advances to customers, net

13

268,482,525

 

233,824,745

Derivative financial instruments

1,677,011

 

1,101,896

Financial investments

 

 

 

- Financial Assets at Fair Value through P&L

14

974,297

 

-

- Financial Assets at Fair Value through OCI

14

248,351,476

 

232,290,598

- Financial Assets at Amortized cost

14

92,820,896

 

37,847,114

- Investments in subsidiaries and associates

15

671,525

 

671,525

Non current assets held for sale

28

159,828

 

159,828

Other assets

16

24,919,564

 

18,929,067

Deferred tax assets

1,936,004

 

1,685,223

Property and equipment

17

2,703,062

 

2,737,936

Total assets

 

972,359,181

 

832,527,142

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

18

5,572,065

 

12,427,384

Due to customers

19

792,409,197

 

675,310,076

Derivative financial instruments

602,480

 

140,934

Current income tax liabilities

5,445,769

 

9,395,534

Other liabilities

20

29,842,663

 

18,307,580

Issued debt instruments

21

4,699,516

 

3,073,349

Other loans

19,184,788

 

12,483,907

Other provisions

22

14,699,408

 

11,088,372

Total liabilities

 

872,455,886

 

742,227,136

Equity

 

 

 

Issued and paid up capital

30,195,010

 

30,195,010

Reserves

55,513,384

 

29,388,626

Reserve for employee stock ownership plan (ESOP)

1,786,010

 

1,486,010

Retained earnings *

12,408,891

 

29,230,360

Total equity and net profit for the period / year

 

99,903,295

 

90,300,006

Total liabilities and equity

 

972,359,181

 

832,527,142

The accompanying notes are an integral part of these financial statements.

 

( Limited Review report attached )

 

*

Including net profit for the period

 

Hussein Abaza

Hisham Ezz Al-Arab

 

CEO & Managing Director

Chairman

 

 

 

Condensed Separate Interim Income Statement for the period ended March 31, 2024

 

Notes

Mar. 31, 2024

 

Mar. 31, 2023

 

 

 

 

Interest and similar income

36,544,341

 

19,729,848

Interest and similar expense

(17,784,185)

 

(8,897,778)

Net interest income

 

18,760,156

 

10,832,070

 

 

Fee and commission income

2,684,283

 

2,004,350

Fee and commission expense

(1,118,950)

 

(792,102)

Net fee and commission income

 

1,565,333

 

1,212,248

 

 

Dividend income

610

 

32,362

Net trading income

6

16,202,679

 

1,845,604

Profits (Losses) on financial investments 

14.1

224,271

 

70,920

Administrative expenses

(2,840,462)

 

(2,004,617)

Other operating income (expenses)

7

(14,923,188)

 

(1,969,625)

Impairment release (charges) for credit losses

(1,482,187)

 

(947,656)

Profit before income tax

 

17,507,212

 

9,071,306

 

 

Income tax expense

26

(5,722,492)

 

(2,264,671)

Deferred tax assets (Liabilities)

26

161,877

 

(722,182)

Net profit for the period

 

11,946,597

 

6,084,453

 

 

Earnings per share

8

 

 

Basic

3.50

 

1.78

Diluted

3.46

 

1.76

 

 

Hussein Abaza

 

Hisham Ezz Al-Arab

CEO & Managing Director

 

Chairman

 

 

Condensed Separate Interim Statement of Comprehensive Income for the period ended March 31, 2024

 

Mar. 31, 2024

 

Mar. 31, 2023

 

 

 

 

Net profit for the period

 

11,946,597

 

6,084,453

 

 

Change in fair value of Financial invesments measured at fair value through comprehensive income after tax

1,977,715

 

(8,507,038)

Transferred to RE from financial assets at fair value through comprehensive income

-

 

(1,895)

Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income

745,406

 

208,250

Total comprehensive income for the period

 

14,669,718

 

(2,216,230)

 

 

 

Condensed Separate Interim Cash Flows for the period ended March 31, 2024

 

Notes

Mar. 31, 2024

 

Mar. 31, 2023

 

 

Cash flow from operating activities

 

 

 

Profit before income tax

17,507,212

 

9,071,306

Adjustments to reconcile profits to net cash provided by operating activities

 

 

 

Fixed assets depreciation

17

261,427

206,400

Impairment Release/charge for credit losses (Loans and advances to customers and banks)

1,772,387

714,714

Other provisions Release/charge

22

40,759

464,368

Impairment Release/charge for credit losses (due from banks)

(53)

(1,549)

Impairment Release/charge for credit losses (financial investments)

(290,147)

234,491

Impairment Release/charge for other assets

(4,782)

-

Exchange revaluation differences for financial assets at fair value through OCI and AC

(17,328,576)

(6,033,831)

Revaluation differences Impairment charge for Financial Assets at Fair value through OCI

1,130,412

-

Revaluation differences Impairment charge for Financial Assets at Amortized cost

95,225

-

Revaluation differences Impairment charge for due from banks

101

-

Utilization of other provisions

22

(297)

(345)

Other provisions no longer used

22

(4,220)

-

Exchange revaluation differences of other provisions

22

3,574,794

1,169,894

Profits/losses from selling property and equipment

-

(118)

Profits/losses from selling financial investments at fair value through OCI

14.1

(224,271)

(70,920)

Share based payments

300,000

190,974

Operating profits before changes in operating assets and liabilities

 

6,829,971

 

5,945,384

 

 

Net decrease / increase in assets and liabilities

 

 

 

Due from banks

42,289,034

12,102,385

Financial assets at fair value through P&L

(974,297)

-

Derivative financial instruments

154,638

(358,715)

Loans and advances to banks and customers

12-13

(36,747,889)

(17,757,613)

Other assets

(5,850,432)

(75,936)

Due to banks

18

(6,855,319)

4,811,010

Due to customers

19

117,099,122

43,988,897

Current income tax obligations paid

(276,723)

(272,736)

Other liabilities

1,851,912

(362,831)

Net cash generated from (used in) operating activities

 

117,520,017

 

48,019,845

 

 

Cash flow from investing activities

 

 

 

Proceeds from sale of investments in associates

4,782

-

Payments for investment in subsidiaries

-

(1,216,022)

Payment for purchases of property, equipment and branches construction

(366,618)

(415,435)

Proceeds from selling property and equipment

-

118

Proceeds from redemption of financial assets at amortized cost

285,507

196,783

Payment for purchases of financial assets at amortized cost

(53,240,480)

(8,454,232)

Payment for purchases of financial assets at fair value through OCI

(26,284,875)

(32,426,908)

Proceeds from selling financial assets at fair value through OCI

26,380,625

46,782,676

Net cash generated from (used in) investing activities

 

(53,221,059)

4,466,980

Condensed Separate Interim Cash Flows for the period ended March 31, 2024 (Cont.)

 

Mar. 31, 2024

 

Mar. 31, 2023

 

 

Cash flow from financing activities

 

 

 

Other loans

6,700,881

1,607,404

Dividends paid

(5,078,792)

(1,964,603)

Issued debt instruments

1,626,167

612,624

Capital increase

-

165,429

Net cash generated from (used in) financing activities

 

3,248,256

420,854

 

 

Net (decrease) increase in cash and cash equivalent during the period

67,547,214

52,907,679

Beginning balance of cash and cash equivalent

233,912,193

 

92,895,143

Cash and cash equivalent at the end of the period

 

301,459,407

 

145,802,822

 

 

Cash and cash equivalent comprise:

 

 

 

Cash and balances at the central bank

9

36,542,863

 

52,319,656

Due from banks

291,980,200

 

169,655,814

Treasury bills and other governmental notes

11

119,754,167

68,681,151

Obligatory reserve balance with CBE

(19,383,018)

 

(45,888,981)

Due from banks with maturity more than three months

(7,554,480)

(29,664,721)

Treasury bills and other governmental notes with maturity more than three months

(119,880,325)

(69,300,097)

Total cash and cash equivalent

 

301,459,407

 

145,802,822

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity

 

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

Mar. 31, 2023

Beginning

 

Balance at 1 Januray 2023

29,825,134

3,963,946

27,096,858

1,549,445

18,947

(13,138,461)

11,981

16,497,346

1,895,435

67,720,631

 

Capital increase

165,429

-

-

-

-

-

-

-

-

165,429

Transferred to reserves

-

806,408

11,998,639

-

2,208

-

-

(12,388,223)

(419,032)

-

Dividend paid

-

-

-

-

-

-

-

(3,738,888)

-

(3,738,888)

Net profit for the period

-

-

-

-

-

-

-

6,084,453

-

6,084,453

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

(1,895)

-

1,895

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

(8,507,038)

-

-

-

(8,507,038)

Transferred (from) to bank risk reserve

-

-

-

-

-

-

3,249

(3,249)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

208,250

-

-

-

208,250

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

190,974

190,974

Balance at 31 March 2023

29,990,563

4,770,354

39,095,497

1,549,445

21,155

(21,439,144)

15,230

6,453,334

1,667,377

62,123,811

Mar. 31, 2024

 

 

 

 

 

 

 

 

 

 

Beginning Balance at 1 Januray 2024

30,195,010

4,770,354

39,840,707

1,549,445

21,155

(16,808,265)

15,230

29,230,360

1,486,010

90,300,006

Capital increase

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

1,438,320

21,958,960

-

1,663

-

-

(23,398,943)

-

-

Dividend paid

-

-

-

-

-

-

-

(5,366,429)

-

(5,366,429)

Net profit for the period

-

-

-

-

-

-

-

11,946,597

-

11,946,597

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

-

-

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

1,977,715

-

-

-

1,977,715

Transferred (from) to banking risk reserve

-

-

-

-

-

-

2,694

(2,694)

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

745,406

-

-

-

745,406

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

300,000

300,000

Balance at 31 March 2024

30,195,010

6,208,674

61,799,667

1,549,445

22,818

(14,085,144)

17,924

12,408,891

1,786,010

99,903,295

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFUUABRSNUVAAR
Date   Source Headline
13th May 20247:00 amRNS1st Quarter Results - Separate Statements
13th May 20247:00 amRNS1st Quarter Results - Consolidated Statements
26th Mar 20247:49 amRNSChanges in CIB's BOD - 25 March 2024
26th Mar 20247:00 amRNSOGM Resolutions - March 25th, 2024
26th Mar 20247:00 amRNSEGM Resolutions - March 25th, 2024
20th Feb 20247:00 amRNSNotice of AGM
20th Feb 20247:00 amRNSInvitation to Extraordinary GM (EGM)
16th Nov 20233:45 pmRNSCIB secures a USD 150M subordinated loan from EBRD
3rd Nov 20237:05 amRNS3rd Quarter Results
3rd Nov 20237:05 amRNS3Q23 Earnings Release
3rd Nov 20237:05 amRNS3rd Quarter Results - Consolidated
23rd Aug 20237:14 amRNSAppointment of Mr. Jawaid Mirza in CIB's BOD
24th Jul 20238:00 amRNSCIB 1H2023 Earnings Release
24th Jul 20238:00 amRNSCIB1H2023 Condensed Consolidated Financials
24th Jul 20238:00 amRNSCIB 1H2023 Separate Condensed Financial Statements
10th Jul 20238:00 amRNSCIB obtaining Long term loans from IFC
15th May 20237:00 amRNSCIB Q1-2023 Separate Financial Statements
15th May 20237:00 amRNSCIB 1Q23 - Earnings Release
15th May 20237:00 amRNSCIB 1Q23 Consolidated Financial Statements
20th Mar 20236:26 pmRNSCIB's FY22 IFRS 9 Financial Statements
20th Mar 20235:02 pmRNSResolutions Extraordinary General Assembly
20th Mar 20234:55 pmRNSResolutions Ordinary General Assembly (OGM)
16th Feb 20237:00 amRNSInvitation to CIB's Ordinary General Assembly
16th Feb 20237:00 amRNSInvitation to CIB's Extraordinary General Assembly
13th Feb 20237:00 amRNSCIB - 4Q 2022 Earnings Release
13th Feb 20237:00 amRNSCIB Q4-2022 Consolidated Financial Statements
13th Feb 20237:00 amRNSCIB Q4-2022 Separate Financial Statements
30th Jan 20237:00 amRNSCIB fully acquires MayFair CIB (Kenya)-Replacement
27th Jan 20235:51 pmRNSCIB fully acquires Mayfair CIB
11th Jan 20234:41 pmRNSSecond Price Monitoring Extn
11th Jan 20234:35 pmRNSPrice Monitoring Extension
8th Dec 202212:25 pmRNSPress Release dated 8 December 2022
22nd Nov 20228:14 amRNSChanges in CIB's Board of Directors
4th Nov 20227:00 amRNS3rd Quarter 2022 (Earnings Release)
4th Nov 20227:00 amRNSBoard Resolutions Summary 3 Nov 2022
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Separate)
4th Nov 20227:00 amRNS3rd Quarter 2022 Results (Consolidated)
15th Aug 20227:00 amRNSChange in CIB's CEO Retail Banking
25th Jul 20227:00 amRNSCIB 1H2022 Condensed Separate Financial Results
25th Jul 20227:00 amRNSCIB1H2022 Earnings Release
25th Jul 20227:00 amRNSCIB1H2022 Consolidated Condensed Financial Results
19th May 20223:09 pmRNSChange in CIB's Board of Directors
29th Apr 202212:17 pmRNSCIB FY 2021 IFRS Annual Financial Report
19th Apr 20227:00 amRNSCIB 1Q2022 Earnings Release
19th Apr 20227:00 amRNSCIB1Q2022 Condensed Consolidated Financial results
19th Apr 20227:00 amRNSCIB 1Q2022 Condensed Separate Results
28th Mar 20227:00 amRNSCIB's AGM Resolutions Summary
10th Mar 20224:41 pmRNSSecond Price Monitoring Extn
10th Mar 20224:36 pmRNSPrice Monitoring Extension
9th Mar 20224:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.